Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
In order to investigate the effectiveness of G-CSF in preventing embryo demise, the
investigators administered this cytokine to women with recurrent miscarriage in a randomized
controlled study compared to women treated with placebo. Sixty eight women with unexplained
primary recurrent miscarriage, all of them with at least four consecutive abortions and
negative for all clinical investigations were selected for this study. Patients were randomly
treated with G-CSF, starting on the 6th day after ovulation, or with placebo.